TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Octapharma AS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
13,127
|
40,756
|
43,913 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
546
|
1,325
|
1,583 |
| Total assets |
3,538
|
12,266
|
14,691 |
| Current assets |
3,519
|
12,257
|
14,683 |
| Current liabilities |
1,022
|
4,809
|
7,912 |
| Equity capital |
2,516
|
7,456
|
6,779 |
| - share capital |
13
|
14
|
15 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
71.1%
|
60.8%
|
46.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
4.2%
|
3.3%
|
3.6% |
| Return on assets (ROA) |
15.4%
|
10.8%
|
10.8% |
| Current ratio |
344.3%
|
254.9%
|
185.6% |
| Return on equity (ROE) |
21.7%
|
17.8%
|
23.4% |
| Change turnover |
-25,040
|
-850
|
8,407 |
| Change turnover % |
-66%
|
-2%
|
24% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.